Open original FDA record ↗Recall record
- FDA identifier
- Z-0168-2023
- Company in FDA record
- Rebiscan, Inc.
- FDA classification date
- Nov 1, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Unable to charge the battery pack- battery packs will allow the batteries to be charged if the voltage of any cell is below 2.5V. When this occurs, the battery pack will not accept the charge, could vent and possibly catch fire
Source facts
- Action
- Rebion issued Urgent Medical Device Removal letter on 10/3/22 via Certified Mail. Letter states reason for recall, health risk and action to take: 1. Return the provided response form acknowledge receipt of this communication. 2. Stop using the device 3. Return the device, along with its power cord and carry case, to Rebion In the event that you have noticed abnormal device behavior related to charging, battery life, or excessive heat while operating the device, then please contact us immediately PLANNED ACTION TO BE TAKEN BY REBION 1. Rebion plans to evaluate and repair each device at no charge. 2. Provide each customer with a postage paid shipping label 3. Upon receipt of the device, Rebion will determine whether the battery pack is affected. 4. Affected battery packs will be replaced. 5. The device will be returned to the customer. FURTHER INFORMATION AND SUPPORT If you need further information or support for this issue, contact your Rebion representative or contact Rebion Customer Service at 877-499-9966.
- Initiated
- 2022-10-03
- Root cause
- Device Design
- Distribution
- Worldwide distribution - US Nationwide and the countries of New Zealand, Belgium.
- Recall number
- Z-0168-2023
- Recall status
- Open, Classified
- CDRH record ID
- 196320
- FDA classified
- 2022-11-01
- Recall event number
- 90968